Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although trazodone is frequently used by fibromyalgia patients, its efficacy on this disease has not been adequately studied. If effective, pregabalin, whose beneficial effects on pain and sleep quality in fibromyalgia have been demonstrated, could complement the antidepressant and anxiolytic effects of trazodone. The aim of the present study was to assess the effectiveness of trazodone alone and in combination with pregabalin in the treatment of fibromyalgia. METHODS: This was an open-label uncontrolled study. Trazodone, flexibly dosed (50-300 mg/day), was administered to 66 fibromyalgia patients during 12 weeks; 41 patients who completed the treatment accepted to receive pregabalin, also flexibly dosed (75-450 mg/day), added to trazodone treatment for an additional 12-week period. Outcome measures included the Fibromyalgia Impact Questionnaire (FIQ), the Pittsburgh Sleep Quality Index (PSQI), the Beck Depression Inventory (BDI), the Hospital Anxiety and Depression Scale (HADS), the Brief Pain Inventory (BPI), the Short-Form Health Survey (SF-36), and the Patients' Global Improvement scale (PGI). Emergent adverse reactions were recorded. Data were analyzed with repeated measures one-way ANOVA and paired Student's t test. RESULTS: Treatment with trazodone significantly improved global fibromyalgia severity, sleep quality, and depression, as well as pain interference with daily activities although without showing a direct effect on bodily pain. After pregabalin combination additional and significant improvements were seen on fibromyalgia severity, depression and pain interference with daily activities, and a decrease in bodily pain was also apparent. During the second phase of the study, only two patients dropped out due to side effects. CONCLUSIONS: Trazodone significantly improved fibromyalgia severity and associated symptomatology. Its combination with pregabalin potentiated this improvement and the tolerability of the drugs in association was good. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00791739.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 1×
“In fact, several observational, prospective and longitudinal studies have found that the use of prescription drugs is high among fibromyalgia patients [9], and that polytherapy is usual, with the mean number of drugs ranging from 2.7 to 3.3 per patient [ 10-12 ].”
BackgroundInfluentialDworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
An internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865 · cited 2×
“In a recent Internet survey of people with fibromyalgia, 33% of the patients reported having used trazodone; within this group, the 36% of respondents reported continuing to use the drug, with 51% finding it useful [4].”
BackgroundQuintana, J. M., Padierna, A., Esteban, C., Arostegui, I., Bilbao, A., & Ruiz, I. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00062.x · Cited by 428
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
MEASE, P., ARNOLD, L. M., CHOY, E. H., CLAUW, D. J., CROFFORD, L. J., GLASS, J. M., MARTIN, S. A., MOREA, J., SIMON, L., STRAND, C. V., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090367 · Cited by 256 · cited 1×
“Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment of fibromyalgia [1].”
BackgroundValidación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica
Badia, X., Muriel, C., Gracia, A., Manuel Núñez-Olarte, J., Perulero, N., Gálvez, R., Carulla, J., & S. Cleeland, C. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73601-x · Cited by 217 · cited 6×
“Trazodone treatment did not improve pain severity, as measured by the BPI, but it had a large impact on pain interference with daily activities, a fact that could also perhaps be attributed to the sleep-improvement Figure 1 Patients flow diagram. properties of the drug.”
MethodInfluential
Cited by
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Depression and chronic pain in the elderly: links and management challenges
Zis, P., Daskalaki, A., Bountouni, I., Sykioti, P., Varrassi, G., & Paladini, A. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s113576 · Cited by 439
Multimodal Treatment of Chronic Pain
Dale, R., & Stacey, B. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.08.012 · Cited by 171
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
“The combination of trazadone (50–300 mg/day) plus pregabalin (75–450 mg/day) has previously been trialled in a two-phase, open-label uncontrolled study for 24 weeks in fibromyalgia [206].”
Background
Metadata
- Authors
- Calandre, E. P., Morillas-Arques, P., Molina-Barea, R., Rodriguez-Lopez, C. M., & Rico-Villademoros, F.
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2011-05-16
- Volume
- 12
- Issue
- 1
- Pages
- 95-95
- ISSN
- 1471-2474 (ISSN-L)
- OpenAlex
- W2103946421
- Cited by
- 52
- References
- 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. https://app.cochat.ai/papers/10.1186/1471-2474-12-95
- The paper
- Calandre, E. P., Morillas-Arques, P., Molina-Barea, R., Rodriguez-Lopez, C. M., & Rico-Villademoros, F. (2011). Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disorders. https://doi.org/10.1186/1471-2474-12-95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.